Terms: = Lymphoma AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF AND Clinical Outcome
1 results:
1. clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (sch 727965) in acute leukemias.
Gojo I; Sadowska M; Walker A; Feldman EJ; Iyer SP; Baer MR; Sausville EA; Lapidus RG; Zhang D; Zhu Y; Jou YM; Poon J; Small K; Bannerji R
Cancer Chemother Pharmacol; 2013 Oct; 72(4):897-908. PubMed ID: 23949430
[TBL] [Abstract] [Full Text] [Related]
